Skip to main navigation Skip to search Skip to main content

ISPAD Clinical Practice Consensus Guidelines 2022: Insulin treatment in children and adolescents with diabetes

  • Eda Cengiz*
  • , Thomas Danne
  • , Tariq Ahmad
  • , Ahila Ayyavoo
  • , David Beran
  • , Sarah Ehtisham
  • , Jan Fairchild
  • , Przemyslawa Jarosz-Chobot
  • , Sze May Ng
  • , Megan Paterson
  • , Ethel Codner
  • *Corresponding author for this work
  • University of California
  • Diabetes Center for Children and Adolescents
  • UCSF Benioff Children's Hospital Oakland
  • G Kuppuswamy Naidu Memorial Hospital
  • University of Geneva
  • Mediclinic City Hospital
  • Women's and Children's Hospital Adelaide
  • Medical University of Silesia
  • Department of Paediatrics
  • Southport & Ormskirk Hospitals NHS Trust
  • Department of Women's and Children's Health
  • University of Liverpool
  • John Hunter Children's Hospital
  • Universidad de Chile

Research output: Contribution to journalArticle (journal)peer-review

Original languageEnglish
Pages (from-to)1277-1296
Number of pages20
JournalPediatric Diabetes
Volume23
Issue number8
DOIs
Publication statusPublished - 20 Dec 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • adolescents
  • children
  • insulin
  • type 1 diabetes
  • Humans
  • Insulins
  • Consensus
  • Practice Patterns, Physicians'
  • Societies, Medical
  • Adolescent
  • Hypoglycemic Agents/therapeutic use
  • Child
  • Diabetes Mellitus, Type 1/therapy

Cite this